Document is current
Any future updates will be listed below
-
Authors
Fernandez, Nicholas R. https://orcid.org/0000-0003-4844-261X
Chang, Yuan
Nunes, Nuno M. https://orcid.org/0000-0002-3879-9757
Dimayacyac, Jose R.
Levine, Adrian
Ringel, Amit
Negm, Logine
Ercan, Ayse Bahar https://orcid.org/0000-0003-3612-3515
Hess, Julian M. https://orcid.org/0000-0003-1387-4009
Ahmad, Olfat
Lee, Caitlin https://orcid.org/0009-0001-4908-3551
Stengs, Lucie
Bianchi, Vanessa
Edwards, Melissa
Doherty, Sheradan
Chung, Jiil
Nobre, Liana
Bennett, Julie https://orcid.org/0000-0002-4146-1511
Dodgshun, Andrew J. https://orcid.org/0000-0003-3288-2047
Jones, David T. W. https://orcid.org/0000-0002-2036-5141
Pfister, Stefan M. https://orcid.org/0000-0002-5447-5322
Villani, Anita
Malkin, David https://orcid.org/0000-0001-5752-9763
Ramaswamy, Vijay https://orcid.org/0000-0002-6557-895X
Huang, Annie
Bouffet, Eric
Aronson, Melyssa https://orcid.org/0000-0002-7503-5799
Dirks, Peter B. https://orcid.org/0000-0001-5718-6465
Shlien, Adam https://orcid.org/0000-0002-0368-5370
Getz, Gad https://orcid.org/0000-0002-0936-0753
Maruvka, Yosef E.
Ertl-Wagner, Birgit
Hawkins, Cynthia https://orcid.org/0000-0003-2618-4402
Das, Anirban https://orcid.org/0000-0001-7653-9529
Tabori, Uri https://orcid.org/0000-0002-5019-2683
- License Information
-
More Information
Article History
Received: 22 April 2025
Accepted: 21 October 2025
First Online: 22 December 2025
Competing interests
: A.S. is a cofounder of, and holds equity in, NewCode Oncology, which has licensed technology from The Hospital for Sick Children (SickKids). C.H. discloses honorarium from Servier. D.T.W.J. is a founder of and stock shareholder in Heidelberg Epignostix GmbH. E.B. discloses participation in an advisory board for Servier. G.G. receives research funds from IBM, Pharmacyclics/AbbVie, Bayer, Genentech, Calico, Ultima Genomics, Inocras, Google, Kite and Novartis, and is also an inventor on patent applications filed by the Broad Institute related to MSMuTect, MSMutSig, POLYSOLVER, SignatureAnalyzer-GPU, MSEye, MinimuMM-seq and DLBclass. He is a founder, consultant and holds privately held equity in Scorpion Therapeutics; is a founder of, and holds privately held equity in, Predicta Biosciences; and holds privately held equity in Antares Therapeutics. J.B. discloses participation in advisory boards for Servier Canada and Alexion-Canada. J.M.H. is an employee of and holds privately held equity in Predicta Biosciences. S.M.P. discloses honoraria from BioSkryb, waived honoraria from Epignostix GmbH, PMC Advisory Board and University Hospital Essen Westdeutsches Tumorzentrum, unpaid memberships in GPOH, SIOP, DGNN, DKG, AACR and SNO, and is a stock shareholder in Epignostix GmbH. The other authors declare no competing interests.
